Vitestro Unveils Autonomous Blood Collection Device, Combining Artificial Intelligence, Ultrasound Imaging and Robotics

ByLance T. Lee

May 30, 2022

Healthcare Shortages Trigger Revolutionary Developments
In healthcare, the clinical laboratory is the driving force. The accuracy and speed of lab tests are critically important, as they shape approximately 70% of all medical decisions made by doctors. It’s no surprise that blood sampling (“phlebotomy”) is the most common invasive medical procedure, performed billions of times a year worldwide. Blood collection plays a central role in clinical diagnostics, but is also hampered by the shortage of skilled workers. By automating this labor-intensive procedure, we can transform the quality of care and create a sustainable healthcare system.

Patented lab automation technology standardizes blood sample handling while blood is drawn. The device allows almost complete automation of the pre-analytical phase. This has the potential to reduce the high rates of blood test errors, primarily caused by manual variability. In clinical studies, Vitestro has already taken 1,500 automated blood samples from more than 1,000 patients with its prototype.

Toon Overbeeke, co-founder and CEO of Vitestro said:

“The growing shortage of healthcare personnel is imminent. The pandemic has further led to a loss of manpower, leading to a bleak outlook for hospital production worldwide and resulting in reduced access and continuity. That’s why revolutionary automation like our blood collection device is inevitable in solving the industry’s biggest problem.”

Ambulatory phlebotomy care is redefined
Initially, Vitestro will implant the device in outpatient phlebotomy departments. Patients will have the option of choosing between Vitestro’s venipuncture device or the standard method. The device is intuitive to use, allowing patients to be autonomous in the complete blood collection procedure. In past clinical trials, patients of all ages have demonstrated a high degree of openness, enthusiasm and willingness to embrace innovation.

A trained healthcare professional is able to monitor multiple devices and manage multiple patients simultaneously. The increased efficiency allows hospitals and clinical labs to address labor shortages or even free up staff and deploy them to where they are truly needed.

Toon Overbeeke, co-founder and CEO of Vitestro adds:
“We have spent almost five years developing this revolutionary medical device. All the disciplines concerned are represented within our dedicated and specialized team of 35 people. To prepare for production and marketing, the team will double in size over the next two years. We have a clear momentum in the market and we will be the first to bring autonomous technology to European hospitals. With our technology, we can help build a more robust and resilient healthcare system.”

Anja Leyte, Director of OVLG Laboratories, clinical study participant commented:
“By introducing automated blood collection, quality and capacity are guaranteed in our laboratories. Vitestro’s technology is helping to solve staff shortages in our blood collection department and improve sample standardization. Patients are also very enthusiastic .”

About Vitestro
In 2017, the founders of Vitestro took on the challenge of creating a better blood collection experience. Today, Vitestro is on track to achieve its goal with a committed team of 35 highly skilled people with experience in medical robotics, imaging software, AI, QA/AR and business development. Vitestro is based in Utrecht, Netherlands. Vitestro is well funded by private investors and government grants.

www.vitestro.com

Please contact us for more information:

Vitestro, Utrecht, Netherlands
Toon Overbeeke, CEO, Co-Founder,
Such. : +31 30 2004551
E: cartoon.overbeek@Vitestro.com

LifeSpring Life Sciences Communications
Leon Melens
Such. : +31 6 538 16 427
Email: [email protected]

SOURCEVitestro


Source link